765962-66-1 Usage
Chemical structure
A complex organic compound with a unique and specific structure, consisting of a sulfonyl chloride functional group and a 1,4-dioxa-8-azaspiro[4.5]decane moiety.
Reactivity
The compound is highly reactive, particularly due to the presence of the sulfonyl chloride functional group, which can readily undergo nucleophilic substitution reactions.
Synthesis
The compound can be synthesized through various organic synthesis methods, often involving the formation of the spirocyclic structure followed by the introduction of the sulfonyl chloride group.
Stability
The compound may be sensitive to moisture, light, and heat, requiring proper storage conditions to maintain its stability.
Solubility
It is likely to be soluble in organic solvents such as dichloromethane, tetrahydrofuran, or acetone, which are commonly used in organic synthesis.
Hazards
When handling 1,4-Dioxa-8-azaspiro[4.5]decane-8-sulfonyl chloride, it is essential to be aware of potential hazards, including corrosiveness, flammability, and the risk of forming toxic byproducts during reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 765962-66-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,5,9,6 and 2 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 765962-66:
(8*7)+(7*6)+(6*5)+(5*9)+(4*6)+(3*2)+(2*6)+(1*6)=221
221 % 10 = 1
So 765962-66-1 is a valid CAS Registry Number.
765962-66-1Relevant academic research and scientific papers
SUBSTITUTED PIPERIDINE COMPOUNDS
-
Paragraph 0340, (2016/06/01)
The present disclosure provides substituted piperidine compounds having Formula (I), and the pharmaceutically acceptable salts and solvates thereof, wherein R1, B, X, and Z are defined as set forth in the specification. The present disclosure i
AMIDE COMPOUNDS AND THE USE THEREOF
-
Page/Page column 205, (2009/01/24)
The invention relates to amide compounds of Formula I: (I) and pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein: Y is CO or SOm; Z is each optionally substituted lower alkyl, lower alkenyl, cycloalkyl, aryl, heterocyclyl, etc.; R
